Genomic Profile, Radiological and Clinical Features of IDH Wild-Type WHO Grades II and III Glioma

被引：0
|
作者：
Lin, Xuling [1 ]
Brennan, Cameron [1 ]
Zehir, Ahmet [1 ]
Berger, Michael [1 ]
Solit, David [1 ]
Hyman, David [1 ]
Rosenblum, Marc [1 ]
Huse, Jason [1 ]
Omuro, Antonio [1 ]
机构：
[1] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA
来源：
NEUROLOGY | 2016年 / 86卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P5.254
引用
收藏
页数：2
相关论文
共 50 条
  • [41] EPIGENOMIC TREATMENT FOR IDH WILD-TYPE GRADE III GLIOMA, TARGETING DYSREGULATION OF EZH2-H3K27me3
    Ohka, Fumiharu
    Deguchi, Shouichi
    Suzuki, Hiromichi
    Aoki, Kosuke
    Katsushima, Keisuke
    Shinjo, Keiko
    Wakabayashi, Toshihiko
    Kondo, Yutaka
    Natsume, Atsushi
    NEURO-ONCOLOGY, 2016, 18 : 66 - 66
  • [42] Clinical, radiological profile and outcome in pediatric Spetzler–Martin grades I–III arteriovenous malformations
    Anup P. Nair
    Raj Kumar
    Anant Mehrotra
    A. K. Srivastava
    Rabi Narayan Sahu
    Prakash Nair
    Child's Nervous System, 2012, 28 : 593 - 598
  • [43] EPIGENOMIC TREATMENT FOR IDH WILD-TYPE GRADE III GLIOMA, TARGETING DYSREGULATION OF EZH-2H3K27me3
    Ohka, Fumiharu
    Deguchi, Shouichi
    Suzuki, Hiromichi
    Aoki, Kosuke
    Karsushima, Keisuke
    Shinjo, Keiko
    Wakabayashi, Toshihiko
    Kondo, Yutaka
    Natsume, Atsushi
    NEURO-ONCOLOGY, 2016, 18 : 66 - 67
  • [44] In silico gene expression analysis reveals glycolysis and acetate anaplerosis in IDH1 wild-type glioma and lactate and glutamate anaplerosis in IDH1-mutated glioma
    Khurshed, Mohammed
    Molenaar, Remco J.
    Lenting, Krissie
    Leenders, William P.
    van Noorden, Cornelis J. F.
    ONCOTARGET, 2017, 8 (30) : 49165 - 49177
  • [45] Development and external validation of a clinical prediction model for survival in patients with IDH wild-type glioblastoma
    Mijderwijk, Hendrik-Jan
    Nieboer, Daan
    Incekara, Fatih
    Berger, Kerstin
    Steyerberg, Ewout W.
    van den Bent, Martin J.
    Reifenberger, Guido
    Hanggi, Daniel
    Smits, Marion
    Senft, Christian
    Rapp, Marion
    Sabel, Michael
    Voss, Martin
    Forster, Marie-Therese
    Kamp, Marcel A.
    JOURNAL OF NEUROSURGERY, 2022, 137 (04) : 914 - 923
  • [46] Clinical and molecular features of patients with KRAS wild-type pancreatic adenocarcinoma
    Ben-Ammar, I.
    Tarabay, A.
    Hollebecque, A.
    Tanguy, M.
    Boige, V.
    Malka, D.
    Smolenschi, C.
    Ducreux, M.
    Boileve, A.
    ANNALS OF ONCOLOGY, 2022, 33 : S356 - S356
  • [47] Genomic Profiling Reveals Distinctive Molecular Relapse Patterns in IDH1/2 Wild-Type Glioblastoma
    Riehmer, Vera
    Gietzelt, Jens
    Beyer, Ulrike
    Hentschel, Bettina
    Westphal, Manfred
    Schackert, Gabriele
    Sabel, Michael C.
    Radlwimmer, Bernhard
    Pietsch, Torsten
    Reifenberger, Guido
    Weller, Michael
    Weber, Ruthild G.
    Loeffler, Markus
    GENES CHROMOSOMES & CANCER, 2014, 53 (07): : 589 - 605
  • [48] IDH Wild-type Glioblastoma Presenting with Seizure: Clinical Specificity, and Oncologic and Surgical Outcomes.
    Pesce, Alessandro
    Armocida, Daniele
    Paglia, Francesco
    Palmieri, Mauro
    Frati, Alessandro
    D'Andrea, Giancarlo
    Salvati, Maurizio
    Santoro, Antonio
    JOURNAL OF NEUROLOGICAL SURGERY PART A-CENTRAL EUROPEAN NEUROSURGERY, 2022, 83 (04) : 351 - 360
  • [49] Postoperative Karnofsky performance status prediction in patients with IDH wild-type glioblastoma: A multimodal approach integrating clinical and deep imaging features
    Sasagasako, Tomoki
    Ueda, Akihiko
    Mineharu, Yohei
    Mochizuki, Yusuke
    Doi, Souichiro
    Park, Silsu
    Terada, Yukinori
    Sano, Noritaka
    Tanji, Masahiro
    Arakawa, Yoshiki
    Okuno, Yasushi
    PLOS ONE, 2024, 19 (11):
  • [50] Distinguishing Pseudoprogression From True Early Progression in Isocitrate Dehydrogenase Wild-Type Glioblastoma by Interrogating Clinical, Radiological, and Molecular Features
    Li, Mingxiao
    Ren, Xiaohui
    Dong, Gehong
    Wang, Jincheng
    Jiang, Haihui
    Yang, Chuanwei
    Zhao, Xuzhe
    Zhu, Qinghui
    Cui, Yong
    Yu, Kefu
    Lin, Song
    FRONTIERS IN ONCOLOGY, 2021, 11
12345